IF is praised for benefits like improved insulin sensitivity, fat loss, and metabolic health
Insurers find themselves in the position of needing to say "yes" or "no" to GLP-1 drugs as more people seek them for weight loss
May 2026: More Wegovy patients have come forward, claiming they experienced non-arteritic anterior ischemic optic neuropathy (NAION) after taking Wegovy based on their doctors instructions
After 1824 h, two-cell embryos were transferred into the oviducts of 0.5 days post coitum (dpc) pseudopregnant ICR females (1823 embryos per oviduct)
People with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, pancreatitis, or severe gastrointestinal conditions should avoid GLP1 weight-loss drugs unless specifically advised by their physician
But their safety in people with RA hasnt been specifically tested or at least those results havent been presented or published yet, Lane adds